[Can the postoperative relapse of Crohn disease be influenced?].
Seinäjoen keskussairaalan sisätautipoliklinikka Hanneksenrinne 7, 60220 Seinäjoki. airi.jussila@fimnet.fi
A
A
Jussila
M
M
Färkkilä
H J
HJ
Järvinen
D000890:Anti-Infective Agents / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003424:Crohn Disease / Q000517:prevention & control* / Q000601:surgery*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D019804:Mesalamine / Q000627:therapeutic use; D008795:Metronidazole / Q000627:therapeutic use; D011183:Postoperative Complications / Q000517:prevention & control; D012008:Recurrence
D000890:Anti-Infective Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D007166:Immunosuppressive Agents; D008795:Metronidazole; D019804:Mesalamine; D001379:Azathioprine